. 2012 Nov 7;7(11):e48613. doi: 10.1371/journal.pone.0048613

Table 5. Effect of treatment with 10 μM MG132 from 0–6 or 16–22 h of maturation on meiotic maturation at 22 h after initiation of maturation (Experiment 5).^a .

MG132, 0–6 h	MG132, 16–22 h	No. of oocytes	Nuclear status, % ^b
			GVBD		MI	Ana-Telo	MII
No	No	91	0.9±1.2^c		14.2±0.8^c	0.0±2.9^c	84.9±3.5^c
No	Yes	79	0.0±1.2^c		19.1±0.8^d	6.0±2.9^c	74.8±3.5^c
Yes	No	69	0.0±1.2^c		34.8±0.8^e	3.2±2.9^c	62.0±3.5^c
Yes	Yes	69	1.6±1.2^c		34.7±0.8^e	3.6±2.9^c	60.2±3.5^c
Probability of treatment effects^f
MG132, 0–6				N.S.	N.S.	N.S.	N.S.
MG132, 16–22				N.S.	N.S.	N.S.	N.S.
Interaction				N.S.	P<0.09	N.S.	N.S.

Data are least-squares means ± SEM of values from three replicates.

GVBD: germinal vesicle break down; MI: metaphase I; Ana-Telo: anaphase – telophase; MII: metaphase II.

^c,d,e

Values in the same column with different superscript letters are significantly different (P<0.05 or, for).

N.S. = non-significant (P>0.10).

Table 5. Effect of treatment with 10 μM MG132 from 0–6 or 16–22 h of maturation on meiotic maturation at 22 h after initiation of maturation (Experiment 5).a .